Lung  ||| S:0 E:5 ||| NNP
injury  ||| S:5 E:12 ||| NN
associated  ||| S:12 E:23 ||| VBN
with  ||| S:23 E:28 ||| IN
severe  ||| S:28 E:35 ||| JJ
Epstein-Barr  ||| S:35 E:48 ||| JJ
virus  ||| S:48 E:54 ||| NN
( ||| S:54 E:55 ||| -LRB-
EBV ||| S:55 E:58 ||| NNP
)  ||| S:58 E:60 ||| -RRB-
infection  ||| S:60 E:70 ||| FW
Severe  ||| S:70 E:77 ||| FW
Epstein-Barr  ||| S:77 E:90 ||| FW
( ||| S:90 E:91 ||| -LRB-
EB ||| S:91 E:93 ||| NNP
)  ||| S:93 E:95 ||| -RRB-
virus  ||| S:95 E:101 ||| NN
infection  ||| S:101 E:111 ||| NN
is  ||| S:111 E:114 ||| VBZ
potentially  ||| S:114 E:126 ||| RB
a  ||| S:126 E:128 ||| DT
devastating  ||| S:128 E:140 ||| JJ
process  ||| S:140 E:148 ||| NN
that  ||| S:148 E:153 ||| WDT
often  ||| S:153 E:159 ||| RB
leads  ||| S:159 E:165 ||| VBZ
to  ||| S:165 E:168 ||| TO
death  ||| S:168 E:174 ||| NN
encountered  ||| S:174 E:186 ||| VBD
in  ||| S:186 E:189 ||| IN
pediatrics  ||| S:189 E:200 ||| VBG
recently ||| S:200 E:208 ||| RB
.  ||| S:208 E:210 ||| .
Inappropriate  ||| S:210 E:224 ||| JJ
control  ||| S:224 E:232 ||| NN
of  ||| S:232 E:235 ||| IN
EB  ||| S:235 E:238 ||| NNP
virus  ||| S:238 E:244 ||| NN
replication  ||| S:244 E:256 ||| NNS
may  ||| S:256 E:260 ||| MD
cause  ||| S:260 E:266 ||| VB
severe  ||| S:266 E:273 ||| JJ
infection  ||| S:273 E:283 ||| NN
resulting  ||| S:283 E:293 ||| VBG
in  ||| S:293 E:296 ||| IN
multiple  ||| S:296 E:305 ||| JJ
organ  ||| S:305 E:311 ||| NN
dysfunction ||| S:311 E:322 ||| NN
.  ||| S:322 E:324 ||| .
However ||| S:324 E:331 ||| RB
,  ||| S:331 E:333 ||| ,
little  ||| S:333 E:340 ||| JJ
information  ||| S:340 E:352 ||| NN
is  ||| S:352 E:355 ||| VBZ
available  ||| S:355 E:365 ||| JJ
on  ||| S:365 E:368 ||| IN
pulmonary  ||| S:368 E:378 ||| JJ
complications  ||| S:378 E:392 ||| NNS
associated  ||| S:392 E:403 ||| VBN
with  ||| S:403 E:408 ||| IN
EB  ||| S:408 E:411 ||| NNP
virus  ||| S:411 E:417 ||| NN
infection ||| S:417 E:426 ||| NN
.  ||| S:426 E:428 ||| .
The  ||| S:428 E:432 ||| DT
aim  ||| S:432 E:436 ||| NN
of  ||| S:436 E:439 ||| IN
the  ||| S:439 E:443 ||| DT
present  ||| S:443 E:451 ||| JJ
study  ||| S:451 E:457 ||| NN
was  ||| S:457 E:461 ||| VBD
to  ||| S:461 E:464 ||| TO
investigate  ||| S:464 E:476 ||| VB
severe  ||| S:476 E:483 ||| JJ
EB  ||| S:483 E:486 ||| NNP
virus  ||| S:486 E:492 ||| NN
( ||| S:492 E:493 ||| -LRB-
EBV ||| S:493 E:496 ||| NNP
)  ||| S:496 E:498 ||| -RRB-
infection  ||| S:498 E:508 ||| VBZ
complicated  ||| S:508 E:520 ||| VBN
with  ||| S:520 E:525 ||| IN
lung  ||| S:525 E:530 ||| NN
injury  ||| S:530 E:537 ||| NN
in  ||| S:537 E:540 ||| IN
pediatric  ||| S:540 E:550 ||| JJ
intensive  ||| S:550 E:560 ||| JJ
care  ||| S:560 E:565 ||| NN
unit  ||| S:565 E:570 ||| NN
( ||| S:570 E:571 ||| -LRB-
PICU ||| S:571 E:575 ||| NNP
) ||| S:575 E:576 ||| -RRB-
,  ||| S:576 E:578 ||| ,
including  ||| S:578 E:588 ||| VBG
clinical  ||| S:588 E:597 ||| JJ
characteristics ||| S:597 E:612 ||| NNS
,  ||| S:612 E:614 ||| ,
laboratory  ||| S:614 E:625 ||| NN
or  ||| S:625 E:628 ||| CC
imaging  ||| S:628 E:636 ||| JJ
feature  ||| S:636 E:644 ||| NN
and  ||| S:644 E:648 ||| CC
outcomes ||| S:648 E:656 ||| NNS
.  ||| S:656 E:658 ||| .
A  ||| S:658 E:660 ||| DT
total  ||| S:660 E:666 ||| NN
of  ||| S:666 E:669 ||| IN
45  ||| S:669 E:672 ||| CD
children  ||| S:672 E:681 ||| NNS
with  ||| S:681 E:686 ||| IN
severe  ||| S:686 E:693 ||| JJ
EBV  ||| S:693 E:697 ||| NNP
infection  ||| S:697 E:707 ||| VBD
seen  ||| S:707 E:712 ||| VBN
in  ||| S:712 E:715 ||| IN
PICU  ||| S:715 E:720 ||| NNP
of  ||| S:720 E:723 ||| IN
Shanghai  ||| S:723 E:732 ||| NNP
Children ||| S:732 E:740 ||| NNP
's  ||| S:740 E:743 ||| POS
Hospital  ||| S:743 E:752 ||| NN
between  ||| S:752 E:760 ||| IN
January  ||| S:760 E:768 ||| NNP
2011  ||| S:768 E:773 ||| CD
and  ||| S:773 E:777 ||| CC
December  ||| S:777 E:786 ||| NNP
2014  ||| S:786 E:791 ||| CD
were  ||| S:791 E:796 ||| VBD
retrospectively  ||| S:796 E:812 ||| VBN
reviewed ||| S:812 E:820 ||| VBN
.  ||| S:820 E:822 ||| .
According  ||| S:822 E:832 ||| VBG
to  ||| S:832 E:835 ||| TO
clinical  ||| S:835 E:844 ||| JJ
characteristics  ||| S:844 E:860 ||| NNS
and  ||| S:860 E:864 ||| CC
imaging  ||| S:864 E:872 ||| JJ
feature ||| S:872 E:879 ||| NN
,  ||| S:879 E:881 ||| ,
45  ||| S:881 E:884 ||| CD
children  ||| S:884 E:893 ||| NNS
were  ||| S:893 E:898 ||| VBD
divided  ||| S:898 E:906 ||| VBN
into  ||| S:906 E:911 ||| IN
non-lung  ||| S:911 E:920 ||| JJ
injury  ||| S:920 E:927 ||| NN
group  ||| S:927 E:933 ||| NN
( ||| S:933 E:934 ||| -LRB-
n  ||| S:934 E:936 ||| FW
=27 ||| S:936 E:939 ||| FW
) ||| S:939 E:940 ||| -RRB-
,  ||| S:940 E:942 ||| ,
lung  ||| S:942 E:947 ||| NN
injury  ||| S:947 E:954 ||| NN
without  ||| S:954 E:962 ||| IN
pulmonary  ||| S:962 E:972 ||| JJ
fibrosis  ||| S:972 E:981 ||| JJ
group ||| S:981 E:986 ||| NN
( ||| S:986 E:987 ||| -LRB-
n  ||| S:987 E:989 ||| CD
=  ||| S:989 E:991 ||| SYM
12 ||| S:991 E:993 ||| CD
)  ||| S:993 E:995 ||| -RRB-
and  ||| S:995 E:999 ||| CC
pulmonary  ||| S:999 E:1009 ||| JJ
fibrosis  ||| S:1009 E:1018 ||| JJ
group  ||| S:1018 E:1024 ||| NN
( ||| S:1024 E:1025 ||| -LRB-
n  ||| S:1025 E:1027 ||| CD
=  ||| S:1027 E:1029 ||| SYM
6 ||| S:1029 E:1030 ||| CD
) ||| S:1030 E:1031 ||| -RRB-
.  ||| S:1031 E:1033 ||| .
In  ||| S:1033 E:1036 ||| IN
totally  ||| S:1036 E:1044 ||| RB
45  ||| S:1044 E:1047 ||| CD
cases  ||| S:1047 E:1053 ||| NNS
of  ||| S:1053 E:1056 ||| IN
severe  ||| S:1056 E:1063 ||| JJ
EBV  ||| S:1063 E:1067 ||| NNP
infection ||| S:1067 E:1076 ||| NN
,  ||| S:1076 E:1078 ||| ,
21  ||| S:1078 E:1081 ||| CD
( ||| S:1081 E:1082 ||| -LRB-
46.7 ||| S:1082 E:1086 ||| CD
% ||| S:1086 E:1087 ||| NN
)  ||| S:1087 E:1089 ||| -RRB-
were  ||| S:1089 E:1094 ||| VBD
male  ||| S:1094 E:1099 ||| JJ
and  ||| S:1099 E:1103 ||| CC
24  ||| S:1103 E:1106 ||| CD
( ||| S:1106 E:1107 ||| -LRB-
53.  ||| S:1107 E:1111 ||| CD
3 ||| S:1111 E:1112 ||| CD
% ||| S:1112 E:1113 ||| NN
)  ||| S:1113 E:1115 ||| -RRB-
were  ||| S:1115 E:1120 ||| VBD
female ||| S:1120 E:1126 ||| JJ
,  ||| S:1126 E:1128 ||| ,
mean  ||| S:1128 E:1133 ||| JJ
age  ||| S:1133 E:1137 ||| NN
was  ||| S:1137 E:1141 ||| VBD
2.  ||| S:1141 E:1144 ||| CD
4  ||| S:1144 E:1146 ||| CD
years ||| S:1146 E:1151 ||| NNS
;  ||| S:1151 E:1153 ||| :
18  ||| S:1153 E:1156 ||| CD
cases  ||| S:1156 E:1162 ||| NNS
were  ||| S:1162 E:1167 ||| VBD
complicated  ||| S:1167 E:1179 ||| VBN
with  ||| S:1179 E:1184 ||| IN
lung  ||| S:1184 E:1189 ||| NN
injury ||| S:1189 E:1195 ||| NN
,  ||| S:1195 E:1197 ||| ,
including  ||| S:1197 E:1207 ||| VBG
8  ||| S:1207 E:1209 ||| CD
male  ||| S:1209 E:1214 ||| NN
and  ||| S:1214 E:1218 ||| CC
10  ||| S:1218 E:1221 ||| CD
female ||| S:1221 E:1227 ||| NN
,  ||| S:1227 E:1229 ||| ,
median  ||| S:1229 E:1236 ||| JJ
age  ||| S:1236 E:1240 ||| NN
was  ||| S:1240 E:1244 ||| VBD
31.  ||| S:1244 E:1248 ||| CD
2  ||| S:1248 E:1250 ||| CD
months ||| S:1250 E:1256 ||| NNS
.  ||| S:1256 E:1258 ||| .
All  ||| S:1258 E:1262 ||| DT
of  ||| S:1262 E:1265 ||| IN
18  ||| S:1265 E:1268 ||| CD
cases  ||| S:1268 E:1274 ||| NNS
presented  ||| S:1274 E:1284 ||| VBN
with  ||| S:1284 E:1289 ||| IN
fever  ||| S:1289 E:1295 ||| NN
and  ||| S:1295 E:1299 ||| CC
cough ||| S:1299 E:1304 ||| NN
,  ||| S:1304 E:1306 ||| ,
15  ||| S:1306 E:1309 ||| CD
of  ||| S:1309 E:1312 ||| IN
them  ||| S:1312 E:1317 ||| PRP
exhibited  ||| S:1317 E:1327 ||| VBP
dyspnea ||| S:1327 E:1334 ||| VBN
, ||| S:1334 E:1335 ||| ,
12  ||| S:1335 E:1338 ||| CD
cases  ||| S:1338 E:1344 ||| NNS
were  ||| S:1344 E:1349 ||| VBD
complicated  ||| S:1349 E:1361 ||| VBN
with  ||| S:1361 E:1366 ||| IN
gasping ||| S:1366 E:1373 ||| NN
,  ||| S:1373 E:1375 ||| ,
and  ||| S:1375 E:1379 ||| CC
6  ||| S:1379 E:1381 ||| CD
cases  ||| S:1381 E:1387 ||| NNS
with  ||| S:1387 E:1392 ||| IN
ARDS ||| S:1392 E:1396 ||| NNP
.  ||| S:1396 E:1398 ||| .
Eight  ||| S:1398 E:1404 ||| CD
cases  ||| S:1404 E:1410 ||| NNS
accepted  ||| S:1410 E:1419 ||| VBD
mechanical  ||| S:1419 E:1430 ||| JJ
ventilation  ||| S:1430 E:1442 ||| NN
for  ||| S:1442 E:1446 ||| IN
acute  ||| S:1446 E:1452 ||| JJ
respiratory  ||| S:1452 E:1464 ||| JJ
distress ||| S:1464 E:1472 ||| NN
;  ||| S:1472 E:1474 ||| :
6  ||| S:1474 E:1476 ||| CD
cases  ||| S:1476 E:1482 ||| NNS
who  ||| S:1482 E:1486 ||| WP
developed  ||| S:1486 E:1496 ||| VBD
pulmonary  ||| S:1496 E:1506 ||| JJ
fibrosis  ||| S:1506 E:1515 ||| NN
had  ||| S:1515 E:1519 ||| VBD
tachypnea ||| S:1519 E:1528 ||| CD
,  ||| S:1528 E:1530 ||| ,
refractory  ||| S:1530 E:1541 ||| JJ
hypoxemia  ||| S:1541 E:1551 ||| NN
and  ||| S:1551 E:1555 ||| CC
hypercapnia ||| S:1555 E:1566 ||| NN
,  ||| S:1566 E:1568 ||| ,
severe  ||| S:1568 E:1575 ||| JJ
pulmonary  ||| S:1575 E:1585 ||| JJ
air  ||| S:1585 E:1589 ||| NN
leak ||| S:1589 E:1593 ||| NN
.  ||| S:1593 E:1595 ||| .
The  ||| S:1595 E:1599 ||| DT
average  ||| S:1599 E:1607 ||| JJ
EBV-DNA  ||| S:1607 E:1615 ||| JJ
level  ||| S:1615 E:1621 ||| NN
in  ||| S:1621 E:1624 ||| IN
peripheral  ||| S:1624 E:1635 ||| JJ
blood  ||| S:1635 E:1641 ||| NN
was  ||| S:1641 E:1645 ||| VBD
4.  ||| S:1645 E:1648 ||| CD
42  ||| S:1648 E:1651 ||| CD
x  ||| S:1651 E:1653 ||| SYM
10 ||| S:1653 E:1655 ||| CD
( ||| S:1655 E:1656 ||| -LRB-
6 ||| S:1656 E:1657 ||| CD
)  ||| S:1657 E:1659 ||| -RRB-
copies ||| S:1659 E:1665 ||| FW
/ ||| S:1665 E:1666 ||| FW
ml  ||| S:1666 E:1669 ||| FW
( ||| S:1669 E:1670 ||| -LRB-
range ||| S:1670 E:1675 ||| NN
:  ||| S:1675 E:1677 ||| :
3.  ||| S:1677 E:1680 ||| CD
25  ||| S:1680 E:1683 ||| CD
x  ||| S:1683 E:1685 ||| SYM
10 ||| S:1685 E:1687 ||| CD
( ||| S:1687 E:1688 ||| -LRB-
3 ||| S:1688 E:1689 ||| LS
)  ||| S:1689 E:1691 ||| -RRB-
-  ||| S:1691 E:1693 ||| :
6.59  ||| S:1693 E:1698 ||| CD
x  ||| S:1698 E:1700 ||| SYM
10 ||| S:1700 E:1702 ||| CD
( ||| S:1702 E:1703 ||| -LRB-
7 ||| S:1703 E:1704 ||| CD
)  ||| S:1704 E:1706 ||| -RRB-
copies ||| S:1706 E:1712 ||| FW
/ ||| S:1712 E:1713 ||| FW
ml ||| S:1713 E:1715 ||| FW
) ||| S:1715 E:1716 ||| -RRB-
.  ||| S:1716 E:1718 ||| .
Anti-EBV  ||| S:1718 E:1727 ||| JJ
antibodies  ||| S:1727 E:1738 ||| NNS
were  ||| S:1738 E:1743 ||| VBD
positive  ||| S:1743 E:1752 ||| JJ
in  ||| S:1752 E:1755 ||| IN
41  ||| S:1755 E:1758 ||| CD
cases ||| S:1758 E:1763 ||| NNS
,  ||| S:1763 E:1765 ||| ,
18  ||| S:1765 E:1768 ||| CD
cases  ||| S:1768 E:1774 ||| NNS
were  ||| S:1774 E:1779 ||| VBD
positive  ||| S:1779 E:1788 ||| JJ
( ||| S:1788 E:1789 ||| -LRB-
+ ||| S:1789 E:1790 ||| NNP
)  ||| S:1790 E:1792 ||| -RRB-
for  ||| S:1792 E:1796 ||| IN
VCA-IgM ||| S:1796 E:1803 ||| NNP
,  ||| S:1803 E:1805 ||| ,
15  ||| S:1805 E:1808 ||| CD
cases  ||| S:1808 E:1814 ||| NNS
were  ||| S:1814 E:1819 ||| VBD
VCA-IgG  ||| S:1819 E:1827 ||| JJ
and  ||| S:1827 E:1831 ||| CC
EA-IgG  ||| S:1831 E:1838 ||| NNP
( ||| S:1838 E:1839 ||| -LRB-
+ ||| S:1839 E:1840 ||| NNP
) ||| S:1840 E:1841 ||| -RRB-
,  ||| S:1841 E:1843 ||| ,
8  ||| S:1843 E:1845 ||| CD
cases  ||| S:1845 E:1851 ||| NNS
VCA-IgM  ||| S:1851 E:1859 ||| JJ
and  ||| S:1859 E:1863 ||| CC
VCA-IgG  ||| S:1863 E:1871 ||| NNP
( ||| S:1871 E:1872 ||| -LRB-
+ ||| S:1872 E:1873 ||| NNP
) ||| S:1873 E:1874 ||| -RRB-
.  ||| S:1874 E:1876 ||| .
The  ||| S:1876 E:1880 ||| DT
radiographic  ||| S:1880 E:1893 ||| JJ
findings  ||| S:1893 E:1902 ||| NNS
revealed  ||| S:1902 E:1911 ||| VBD
pulmonary  ||| S:1911 E:1921 ||| JJ
interstitial  ||| S:1921 E:1934 ||| JJ
infiltrates  ||| S:1934 E:1946 ||| NN
in  ||| S:1946 E:1949 ||| IN
all  ||| S:1949 E:1953 ||| DT
18  ||| S:1953 E:1956 ||| CD
cases  ||| S:1956 E:1962 ||| NNS
with  ||| S:1962 E:1967 ||| IN
lung  ||| S:1967 E:1972 ||| NN
injury ||| S:1972 E:1978 ||| NN
,  ||| S:1978 E:1980 ||| ,
4  ||| S:1980 E:1982 ||| CD
cases  ||| S:1982 E:1988 ||| NNS
with  ||| S:1988 E:1993 ||| IN
segmental  ||| S:1993 E:2003 ||| JJ
consolidation  ||| S:2003 E:2017 ||| NN
and  ||| S:2017 E:2021 ||| CC
2  ||| S:2021 E:2023 ||| CD
cases  ||| S:2023 E:2029 ||| NNS
showed  ||| S:2029 E:2036 ||| VBD
pleural  ||| S:2036 E:2044 ||| JJ
effusions ||| S:2044 E:2053 ||| NN
.  ||| S:2053 E:2055 ||| .
HRCT  ||| S:2055 E:2060 ||| NNP
scanning  ||| S:2060 E:2069 ||| FW
found  ||| S:2069 E:2075 ||| FW
EBV  ||| S:2075 E:2079 ||| FW
associated  ||| S:2079 E:2090 ||| FW
fibrosis  ||| S:2090 E:2099 ||| FW
including  ||| S:2099 E:2109 ||| FW
multifocal  ||| S:2109 E:2120 ||| FW
patches  ||| S:2120 E:2128 ||| FW
and  ||| S:2128 E:2132 ||| CC
diffuse  ||| S:2132 E:2140 ||| JJ
ground-glass  ||| S:2140 E:2153 ||| JJ
attenuation  ||| S:2153 E:2165 ||| NN
in  ||| S:2165 E:2168 ||| IN
both  ||| S:2168 E:2173 ||| DT
lungs ||| S:2173 E:2178 ||| NNS
,  ||| S:2178 E:2180 ||| ,
reticular  ||| S:2180 E:2190 ||| JJ
opacities  ||| S:2190 E:2200 ||| NN
and  ||| S:2200 E:2204 ||| CC
honeycombing  ||| S:2204 E:2217 ||| JJ
changes  ||| S:2217 E:2225 ||| NNS
were  ||| S:2225 E:2230 ||| VBD
observed  ||| S:2230 E:2239 ||| VBN
4  ||| S:2239 E:2241 ||| CD
weeks  ||| S:2241 E:2247 ||| NNS
after  ||| S:2247 E:2253 ||| IN
illness  ||| S:2253 E:2261 ||| NN
onset ||| S:2261 E:2266 ||| NN
.  ||| S:2266 E:2268 ||| .
There  ||| S:2268 E:2274 ||| EX
were  ||| S:2274 E:2279 ||| VBD
significant  ||| S:2279 E:2291 ||| JJ
differences  ||| S:2291 E:2303 ||| NNS
in  ||| S:2303 E:2306 ||| IN
respiratory  ||| S:2306 E:2318 ||| JJ
failure ||| S:2318 E:2325 ||| NN
,  ||| S:2325 E:2327 ||| ,
PICU  ||| S:2327 E:2332 ||| NNP
stay  ||| S:2332 E:2337 ||| NN
( ||| S:2337 E:2338 ||| -LRB-
days ||| S:2338 E:2342 ||| NNS
) ||| S:2342 E:2343 ||| -RRB-
,  ||| S:2343 E:2345 ||| ,
Pediatric  ||| S:2345 E:2355 ||| NNP
risk  ||| S:2355 E:2360 ||| NN
of  ||| S:2360 E:2363 ||| IN
mortality  ||| S:2363 E:2373 ||| NN
III  ||| S:2373 E:2377 ||| NNP
( ||| S:2377 E:2378 ||| -LRB-
PRISM  ||| S:2378 E:2384 ||| NNP
III ||| S:2384 E:2387 ||| NNP
)  ||| S:2387 E:2389 ||| -RRB-
and  ||| S:2389 E:2393 ||| CC
pediatric  ||| S:2393 E:2403 ||| JJ
clinical  ||| S:2403 E:2412 ||| JJ
illness  ||| S:2412 E:2420 ||| NN
score ||| S:2420 E:2425 ||| NN
( ||| S:2425 E:2426 ||| -LRB-
PCIS ||| S:2426 E:2430 ||| NNP
) ||| S:2430 E:2431 ||| -RRB-
,  ||| S:2431 E:2433 ||| ,
serum  ||| S:2433 E:2439 ||| JJ
TNF-α ||| S:2439 E:2444 ||| NN
,  ||| S:2444 E:2446 ||| ,
EBV-DNA  ||| S:2446 E:2454 ||| JJ
levels ||| S:2454 E:2460 ||| NNS
,  ||| S:2460 E:2462 ||| ,
percentage  ||| S:2462 E:2473 ||| NN
of  ||| S:2473 E:2476 ||| IN
NK  ||| S:2476 E:2479 ||| NNP
cells  ||| S:2479 E:2485 ||| NNS
and  ||| S:2485 E:2489 ||| CC
CD4+ ||| S:2489 E:2493 ||| CD
/ ||| S:2493 E:2494 ||| CD
CD8+  ||| S:2494 E:2499 ||| CD
T  ||| S:2499 E:2501 ||| NN
cell  ||| S:2501 E:2506 ||| NN
ratio  ||| S:2506 E:2512 ||| NN
among  ||| S:2512 E:2518 ||| IN
non-lung  ||| S:2518 E:2527 ||| JJ
injury  ||| S:2527 E:2534 ||| NN
group ||| S:2534 E:2539 ||| NN
,  ||| S:2539 E:2541 ||| ,
lung  ||| S:2541 E:2546 ||| NN
injury  ||| S:2546 E:2553 ||| NN
without  ||| S:2553 E:2561 ||| IN
pulmonary  ||| S:2561 E:2571 ||| JJ
fibrosis  ||| S:2571 E:2580 ||| JJ
group  ||| S:2580 E:2586 ||| NN
and  ||| S:2586 E:2590 ||| CC
pulmonary  ||| S:2590 E:2600 ||| JJ
fibrosis  ||| S:2600 E:2609 ||| JJ
group  ||| S:2609 E:2615 ||| NN
( ||| S:2615 E:2616 ||| -LRB-
X2  ||| S:2616 E:2619 ||| CD
=27.  ||| S:2619 E:2624 ||| CD
12 ||| S:2624 E:2626 ||| CD
,  ||| S:2626 E:2628 ||| ,
F  ||| S:2628 E:2630 ||| NN
=  ||| S:2630 E:2632 ||| SYM
85.  ||| S:2632 E:2636 ||| CD
23 ||| S:2636 E:2638 ||| CD
,  ||| S:2638 E:2640 ||| ,
78.  ||| S:2640 E:2644 ||| CD
23 ||| S:2644 E:2646 ||| CD
,  ||| S:2646 E:2648 ||| ,
88.  ||| S:2648 E:2652 ||| CD
68 ||| S:2652 E:2654 ||| CD
,  ||| S:2654 E:2656 ||| ,
323.  ||| S:2656 E:2661 ||| CD
80 ||| S:2661 E:2663 ||| CD
,  ||| S:2663 E:2665 ||| ,
7.  ||| S:2665 E:2668 ||| CD
35 ||| S:2668 E:2670 ||| CD
,  ||| S:2670 E:2672 ||| ,
χ2  ||| S:2672 E:2675 ||| CD
=  ||| S:2675 E:2677 ||| SYM
6.  ||| S:2677 E:2680 ||| CD
71 ||| S:2680 E:2682 ||| CD
,  ||| S:2682 E:2684 ||| ,
12.  ||| S:2684 E:2688 ||| CD
15 ||| S:2688 E:2690 ||| CD
;  ||| S:2690 E:2692 ||| :
all  ||| S:2692 E:2696 ||| DT
P  ||| S:2696 E:2698 ||| NN
< ||| S:2698 E:2700 ||| SYM
0.  ||| S:2700 E:2703 ||| CD
05 ||| S:2703 E:2705 ||| CD
) ||| S:2705 E:2706 ||| -RRB-
.  ||| S:2706 E:2708 ||| .
COX  ||| S:2708 E:2712 ||| NNP
regression  ||| S:2712 E:2723 ||| JJ
analysis  ||| S:2723 E:2732 ||| NN
revealed  ||| S:2732 E:2741 ||| VBD
that  ||| S:2741 E:2746 ||| DT
EBV-DNA  ||| S:2746 E:2754 ||| JJ
and  ||| S:2754 E:2758 ||| CC
serum  ||| S:2758 E:2764 ||| JJ
TNF-α  ||| S:2764 E:2770 ||| JJ
levels  ||| S:2770 E:2777 ||| NNS
were  ||| S:2777 E:2782 ||| VBD
correlated  ||| S:2782 E:2793 ||| VBN
with  ||| S:2793 E:2798 ||| IN
pulmonary  ||| S:2798 E:2808 ||| JJ
fibrosis  ||| S:2808 E:2817 ||| NNS
significantly  ||| S:2817 E:2831 ||| RB
( ||| S:2831 E:2832 ||| -LRB-
OR  ||| S:2832 E:2835 ||| NNP
=  ||| S:2835 E:2837 ||| SYM
3.  ||| S:2837 E:2840 ||| CD
92 ||| S:2840 E:2842 ||| CD
,  ||| S:2842 E:2844 ||| ,
P  ||| S:2844 E:2846 ||| NN
=  ||| S:2846 E:2848 ||| SYM
0.  ||| S:2848 E:2851 ||| CD
04 ||| S:2851 E:2853 ||| CD
;  ||| S:2853 E:2855 ||| :
OR  ||| S:2855 E:2858 ||| NNP
=  ||| S:2858 E:2860 ||| SYM
5.  ||| S:2860 E:2863 ||| CD
95 ||| S:2863 E:2865 ||| CD
,  ||| S:2865 E:2867 ||| ,
P  ||| S:2867 E:2869 ||| NN
=  ||| S:2869 E:2871 ||| SYM
0.  ||| S:2871 E:2874 ||| CD
01 ||| S:2874 E:2876 ||| CD
) ||| S:2876 E:2877 ||| -RRB-
.  ||| S:2877 E:2879 ||| .
The  ||| S:2879 E:2883 ||| DT
patients  ||| S:2883 E:2892 ||| NNS
with  ||| S:2892 E:2897 ||| IN
EBV-associated  ||| S:2897 E:2912 ||| JJ
hemophagocytic  ||| S:2912 E:2927 ||| JJ
lymphohistiocytosis  ||| S:2927 E:2947 ||| NNS
( ||| S:2947 E:2948 ||| -LRB-
EBV-HLH ||| S:2948 E:2955 ||| NNP
)  ||| S:2955 E:2957 ||| -RRB-
had  ||| S:2957 E:2961 ||| VBD
higher  ||| S:2961 E:2968 ||| JJR
incidence  ||| S:2968 E:2978 ||| NN
of  ||| S:2978 E:2981 ||| IN
pulmonary  ||| S:2981 E:2991 ||| NNS
fibrosis  ||| S:2991 E:3000 ||| VBP
compared  ||| S:3000 E:3009 ||| VBN
with  ||| S:3009 E:3014 ||| IN
non-EB-HLH  ||| S:3014 E:3025 ||| NNP
( ||| S:3025 E:3026 ||| -LRB-
70 ||| S:3026 E:3028 ||| CD
%  ||| S:3028 E:3030 ||| NN
vs.  ||| S:3030 E:3034 ||| IN
13 ||| S:3034 E:3036 ||| CD
% ||| S:3036 E:3037 ||| NN
,  ||| S:3037 E:3039 ||| ,
χ2  ||| S:3039 E:3042 ||| CD
=  ||| S:3042 E:3044 ||| SYM
4.  ||| S:3044 E:3047 ||| CD
82 ||| S:3047 E:3049 ||| CD
,  ||| S:3049 E:3051 ||| ,
P  ||| S:3051 E:3053 ||| NN
=  ||| S:3053 E:3055 ||| SYM
0.  ||| S:3055 E:3058 ||| CD
03 ||| S:3058 E:3060 ||| CD
) ||| S:3060 E:3061 ||| -RRB-
.  ||| S:3061 E:3063 ||| .
Of  ||| S:3063 E:3066 ||| IN
18  ||| S:3066 E:3069 ||| CD
cases ||| S:3069 E:3074 ||| NNS
,  ||| S:3074 E:3076 ||| ,
8  ||| S:3076 E:3078 ||| CD
cases  ||| S:3078 E:3084 ||| NNS
died ||| S:3084 E:3088 ||| VBD
,  ||| S:3088 E:3090 ||| ,
including  ||| S:3090 E:3100 ||| VBG
3  ||| S:3100 E:3102 ||| CD
cases  ||| S:3102 E:3108 ||| NNS
with  ||| S:3108 E:3113 ||| IN
pulmonary  ||| S:3113 E:3123 ||| JJ
fibrosis ||| S:3123 E:3131 ||| NN
.  ||| S:3131 E:3133 ||| .
The  ||| S:3133 E:3137 ||| DT
surviving  ||| S:3137 E:3147 ||| JJ
cases  ||| S:3147 E:3153 ||| NNS
with  ||| S:3153 E:3158 ||| IN
pulmonary  ||| S:3158 E:3168 ||| JJ
fibrosis  ||| S:3168 E:3177 ||| NN
needed  ||| S:3177 E:3184 ||| VBD
longer  ||| S:3184 E:3191 ||| RBR
additional  ||| S:3191 E:3202 ||| JJ
oxygen ||| S:3202 E:3208 ||| NN
.  ||| S:3208 E:3210 ||| .
Chest  ||| S:3210 E:3216 ||| NNP
HRCT  ||| S:3216 E:3221 ||| NNP
imaging  ||| S:3221 E:3229 ||| NN
of  ||| S:3229 E:3232 ||| IN
3  ||| S:3232 E:3234 ||| CD
cases  ||| S:3234 E:3240 ||| NNS
with  ||| S:3240 E:3245 ||| IN
pulmonary  ||| S:3245 E:3255 ||| JJ
fibrosis  ||| S:3255 E:3264 ||| NN
was  ||| S:3264 E:3268 ||| VBD
improved  ||| S:3268 E:3277 ||| VBN
at  ||| S:3277 E:3280 ||| IN
6  ||| S:3280 E:3282 ||| CD
months  ||| S:3282 E:3289 ||| NNS
and  ||| S:3289 E:3293 ||| CC
oxygen  ||| S:3293 E:3300 ||| JJ
therapy  ||| S:3300 E:3308 ||| NN
was  ||| S:3308 E:3312 ||| VBD
discontinued  ||| S:3312 E:3325 ||| VBN
at  ||| S:3325 E:3328 ||| IN
18  ||| S:3328 E:3331 ||| CD
months  ||| S:3331 E:3338 ||| NNS
after  ||| S:3338 E:3344 ||| IN
discharge ||| S:3344 E:3353 ||| NN
.  ||| S:3353 E:3355 ||| .
EB  ||| S:3355 E:3358 ||| NNP
virus  ||| S:3358 E:3364 ||| NN
infection  ||| S:3364 E:3374 ||| NN
complicated  ||| S:3374 E:3386 ||| VBN
with  ||| S:3386 E:3391 ||| IN
lung  ||| S:3391 E:3396 ||| NN
injury  ||| S:3396 E:3403 ||| NN
had  ||| S:3403 E:3407 ||| VBD
higher  ||| S:3407 E:3414 ||| JJR
incidence  ||| S:3414 E:3424 ||| NN
of  ||| S:3424 E:3427 ||| IN
respiratory  ||| S:3427 E:3439 ||| JJ
failure ||| S:3439 E:3446 ||| NN
,  ||| S:3446 E:3448 ||| ,
pulmonary  ||| S:3448 E:3458 ||| JJ
fibrosis  ||| S:3458 E:3467 ||| NN
with  ||| S:3467 E:3472 ||| IN
a  ||| S:3472 E:3474 ||| DT
fatal  ||| S:3474 E:3480 ||| JJ
outcome ||| S:3480 E:3487 ||| NN
.  ||| S:3487 E:3489 ||| .
EBV-DNA  ||| S:3489 E:3497 ||| NNP
and  ||| S:3497 E:3501 ||| CC
serum  ||| S:3501 E:3507 ||| JJ
TNF-α  ||| S:3507 E:3513 ||| JJ
level  ||| S:3513 E:3519 ||| NN
were  ||| S:3519 E:3524 ||| VBD
found  ||| S:3524 E:3530 ||| VBN
to  ||| S:3530 E:3533 ||| TO
be  ||| S:3533 E:3536 ||| VB
statistically  ||| S:3536 E:3550 ||| RB
significant  ||| S:3550 E:3562 ||| JJ
indicators  ||| S:3562 E:3573 ||| NNS
of  ||| S:3573 E:3576 ||| IN
pulmonary  ||| S:3576 E:3586 ||| JJ
fibrosis ||| S:3586 E:3594 ||| NN
.  ||| S:3594 E:3596 ||| .
Pulmonary  ||| S:3596 E:3606 ||| NNP
fibrosis  ||| S:3606 E:3615 ||| VBD
associated  ||| S:3615 E:3626 ||| VBN
with  ||| S:3626 E:3631 ||| IN
severe  ||| S:3631 E:3638 ||| JJ
EB  ||| S:3638 E:3641 ||| NNP
virus  ||| S:3641 E:3647 ||| NN
infection  ||| S:3647 E:3657 ||| NN
may  ||| S:3657 E:3661 ||| MD
be  ||| S:3661 E:3664 ||| VB
reversible ||| S:3664 E:3674 ||| JJ
.  ||| S:3674 E:3676 ||| .
[ ||| S:3676 E:3677 ||| -LRB-
Key  ||| S:3677 E:3681 ||| JJ
words ||| S:3681 E:3686 ||| NNS
]  ||| S:3686 E:3688 ||| -RRB-
Pulmonary  ||| S:3688 E:3698 ||| NNP
fibrosis ||| S:3698 E:3706 ||| NN
;  ||| S:3706 E:3708 ||| :
Lymphohistiocytosis ||| S:3708 E:3727 ||| NNP
,  ||| S:3727 E:3729 ||| ,
hemophagocytic ||| S:3729 E:3743 ||| NNS
;  ||| S:3743 E:3745 ||| :
Child  ||| S:3745 E:3751 ||| LS
